Michael Gelband’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Buy
+4,442
New +$240K ﹤0.01% 1377
2025
Q1
Sell
-5,761
Closed -$589K 1501
2024
Q4
$589K Buy
+5,761
New +$660K ﹤0.01% 1107
2024
Q2
Sell
-2,520
Closed -$328K 1550
2024
Q1
$328K Sell
2,520
-3,239
-56% -$381K ﹤0.01% 1240
2023
Q4
$653K Buy
+5,759
New +$499K ﹤0.01% 963
2022
Q4
Sell
-5,704
Closed -$354K 1666
2022
Q3
$354K Buy
5,704
+1,272
+29% +$91.7K ﹤0.01% 1470
2022
Q2
$296K Sell
4,432
-3,468
-44% -$261K ﹤0.01% 1544
2022
Q1
$568K Buy
+7,900
New +$647K 0.01% 1454
2021
Q4
Sell
-9,861
Closed -$482K 2187
2021
Q3
$482K Buy
+9,861
New +$496K 0.01% 1420
2021
Q2
Sell
-32,761
Closed -$1.28M 2372
2021
Q1
$1.28M Sell
32,761
-6,471
-16% -$251K 0.02% 776
2020
Q4
$1.15M Buy
+39,232
New +$1M 0.01% 784

Other funds holding BXC

Michael Gelband's BXC Position: Q2 2026 in Review

Michael Gelband opened a new position in BlueLinx (BXC) in Q2 2026: 4,442 shares worth $275K. The stake represents ﹤0.01% of the portfolio and ranks #1377 among its holdings. This is a return to the name: Michael Gelband previously reported a position in BXC as recently as Q4 2024.

Michael Gelband first reported a position in BXC in Q4 2020 and has held it in 10 quarters since. The position peaked at $1.28M in Q1 2021. 157 funds tracked by Wall St. Rank hold BXC as of Q2 2026.

  • Michael Gelband held 4,442 shares of BlueLinx worth $275K as of Q2 2026.
  • BlueLinx was a new Michael Gelband position in Q2 2026.
  • BlueLinx made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1377 holding.
  • Michael Gelband first reported a position in BlueLinx in Q4 2020 and has held it in 10 quarters since.
  • Michael Gelband's BlueLinx position peaked at $1.28M in Q1 2021.
  • 157 funds tracked by Wall St. Rank held BlueLinx as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.